When AI designs a drug, who gets the credit?
When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “disco
Journal
technologyreview.com
21.08.2026